Abstract
Coronavirus disease-2019, a viral disease caused by the novel severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), was identified by the Centre for Disease Control (CDC), China, on January 7, 2020. This mysterious respiratory epidemic occurred in Wuhan, China, in late December 2019. A month after its outbreak in China, the World Health Organization (WHO) declared it as a public health emergency of international concern (PHEIC) due to its severity and high transmission potential throughout the world, leading many nations to implement multiple lockdown sessions and strict social distancing measures. As of September 21, 2020, 30,675,675 active cases and 954,417 deaths had been reported worldwide. Intensive research is being carried out across the globe to identify precise diagnostic techniques and develop novel, effective vaccines against the virus. Herein, we elaborate on details of epidemiology, genetics, pathophysiology, diagnosis, prevention, and vaccine trials related to this pandemic.
Keywords: COVID-19, global outbreak, novel coronavirus, pathogenesis, SARS-CoV-2, vaccines.
Graphical Abstract
Coronaviruses
Title:2019 Novel Coronavirus: A Review on Epidemiology, Pathophysiology, Diagnosis and Current Clinical Trials in Vaccine Development
Volume: 2 Issue: 8
Author(s): Megala Jayaraman*, Sabari Krishna B. B., Parijat Dutta, Jayesh Telang, Sreshta Adhikari and Arpan Neeraj Pardeshi
Affiliation:
- Department of Genetic Engineering, Faculty of Engineering and Technology, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur-603203, Chennai, Tamil Nadu,India
Keywords: COVID-19, global outbreak, novel coronavirus, pathogenesis, SARS-CoV-2, vaccines.
Abstract: Coronavirus disease-2019, a viral disease caused by the novel severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), was identified by the Centre for Disease Control (CDC), China, on January 7, 2020. This mysterious respiratory epidemic occurred in Wuhan, China, in late December 2019. A month after its outbreak in China, the World Health Organization (WHO) declared it as a public health emergency of international concern (PHEIC) due to its severity and high transmission potential throughout the world, leading many nations to implement multiple lockdown sessions and strict social distancing measures. As of September 21, 2020, 30,675,675 active cases and 954,417 deaths had been reported worldwide. Intensive research is being carried out across the globe to identify precise diagnostic techniques and develop novel, effective vaccines against the virus. Herein, we elaborate on details of epidemiology, genetics, pathophysiology, diagnosis, prevention, and vaccine trials related to this pandemic.
Export Options
About this article
Cite this article as:
Jayaraman Megala *, B. B. Krishna Sabari , Dutta Parijat , Telang Jayesh , Adhikari Sreshta and Pardeshi Neeraj Arpan , 2019 Novel Coronavirus: A Review on Epidemiology, Pathophysiology, Diagnosis and Current Clinical Trials in Vaccine Development, Coronaviruses 2021; 2 (8) : e260721189629 . https://dx.doi.org/10.2174/2666796701666201230104321
DOI https://dx.doi.org/10.2174/2666796701666201230104321 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part-I)
Current Pharmaceutical Design B Cells: Programmers of CD4 T Cell Responses
Infectious Disorders - Drug Targets Possible Benefits of Reformulating Antiviral Drugs with Nanoemulsion System in the Treatment of Novel Coronavirus Infection
Coronaviruses Do We have the Evidence to Repurpose Levamisole for Treatment of COVID 19?
Current Drug Therapy Possible Therapeutic Interventions in COVID-19 Induced ARDS by Cotinine as an ACE-2 Promoter and AT-1R Blocker
Infectious Disorders - Drug Targets Symptoms, Transmission, Prevention and Treatment of Pandemic Corona Virus: A Review
Coronaviruses An Urgent Industrial Scheme Both for Total Synthesis, and for Pharmaceutical Analytical Analysis of Umifenovir as an Anti-viral API for Treatment of COVID-19
Combinatorial Chemistry & High Throughput Screening Can Mandated BCG Vaccine Promote herd Immunity against Novel Coronavirus? A Potential Solution at Hand to Tackle Covid-19 Pandemic
Current Immunology Reviews (Discontinued) <i>In Silico</i> Identification of Potential Inhibitors of SARS-CoV-2 Papain-like Protease From Natural Sources: A Natural Weapon to Fight COVID-19
Coronaviruses Review on Diagnostic Methods for SARS-CoV-2
Coronaviruses Patent Selections
Recent Patents on Anti-Infective Drug Discovery Discovery of Potent Anti-SARS-CoV MPro Inhibitors
Current Computer-Aided Drug Design Construction, Expression, Purification and Biotin Labeling of a Single Recombinant Multi-Epitope Antigen for Double-Antigen Sandwich ELISA to Detect Hepatitis C Virus Antibody
Protein & Peptide Letters Crosstalk Between Covid-19 and Associated Neurological Disorders: A Review
Current Neuropharmacology Potential Immunotherapy against SARS-CoV-2: Strategy and Status
Coronaviruses Quantification of Glycyrrhetic Acid in Human Plasma by LC–MS/MS: Application to a Pharmacokinetic Study
Current Pharmaceutical Analysis The Effect of Potato Almond Orange Cookies on their Weight, BMI, Hemoglobin, and Lymphocyte Status of Undernourished Older People during COVID-19 Pandemic
Current Nutrition & Food Science Building Biological Complexity with Limited Genes
Current Genomics Pulmonary Rehabilitation in COVID-19: The Contribution of other Chronic Lung Syndromes for the Intervention of a Novel Disease
Current Respiratory Medicine Reviews Survival Analysis Based on the Siddha Body Constitution of Asymptomatic SARS-CoV-2 Patients Under Integrative Management of Hydroxychloroquine (HCQ) and Kaba Sura Kudineer (KSK): A Retrospective Cross-sectional Case Series from Tirupati
Current Traditional Medicine